IQVIA HOLDINGS INC. Payments to Noncontrolling Interests
IQVIA HOLDINGS INC. (IQV) reported Payments to Noncontrolling Interests of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToMinorityShareholders · last filed 2024-02-15
- IQVIA HOLDINGS INC. payments to noncontrolling interests for the quarter ending 2022-12-31 was $0.00.
- IQVIA HOLDINGS INC. payments to noncontrolling interests for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- IQVIA HOLDINGS INC. payments to noncontrolling interests for the quarter ending 2021-12-31 was $0.00.
- IQVIA HOLDINGS INC. payments to noncontrolling interests for the quarter ending 2021-09-30 was $2.00M.
- IQVIA HOLDINGS INC. payments to noncontrolling interests for fiscal 2023 was $0.00.
- IQVIA HOLDINGS INC. payments to noncontrolling interests for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- IQVIA HOLDINGS INC. payments to noncontrolling interests for fiscal 2021 was $758.00M.
- IQVIA HOLDINGS INC. payments to noncontrolling interests for fiscal 2020 was $0.00.
| Period end | Payments to Noncontrolling Interests 3 month | Payments to Noncontrolling Interests 6 month | Payments to Noncontrolling Interests 9 month | Payments to Noncontrolling Interests 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-15 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-15 | $0.00 10-K · filed 2024-02-15 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-07-22 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $2.00M derived: sum of 2 quarters · filed 2024-02-15 | $758.00M 10-K · filed 2024-02-15 | |
| 2021-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $758.00M 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | $756.00M 10-Q · filed 2022-07-22 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $0.00 derived: sum of 2 quarters · filed 2023-02-15 | $0.00 10-K · filed 2023-02-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $0.00 10-Q · filed 2021-10-22 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |